Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.41 - $0.91 $17,602 - $39,068
-42,932 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$0.79 - $1.59 $2,386 - $4,803
-3,021 Reduced 6.57%
42,932 $36,000
Q4 2021

Feb 11, 2022

SELL
$1.36 - $2.94 $1,871 - $4,045
-1,376 Reduced 2.91%
45,953 $62,000
Q3 2021

Nov 12, 2021

SELL
$2.97 - $4.84 $3,335 - $5,435
-1,123 Reduced 2.32%
47,329 $142,000
Q2 2021

Aug 13, 2021

BUY
$3.71 - $5.13 $26,500 - $36,643
7,143 Added 17.29%
48,452 $224,000
Q1 2021

May 07, 2021

BUY
$4.08 - $14.75 $448 - $1,622
110 Added 0.27%
41,309 $178,000
Q4 2020

Feb 12, 2021

BUY
$11.06 - $14.01 $45,744 - $57,945
4,136 Added 11.16%
41,199 $456,000
Q3 2020

Nov 04, 2020

SELL
$10.26 - $14.55 $81,679 - $115,832
-7,961 Reduced 17.68%
37,063 $449,000
Q2 2020

Aug 12, 2020

BUY
$7.11 - $13.76 $32,727 - $63,337
4,603 Added 11.39%
45,024 $620,000
Q1 2020

May 04, 2020

SELL
$5.71 - $15.85 $13,344 - $37,041
-2,337 Reduced 5.47%
40,421 $313,000
Q4 2019

Feb 05, 2020

SELL
$9.6 - $17.75 $3,446 - $6,372
-359 Reduced 0.83%
42,758 $653,000
Q3 2019

Nov 08, 2019

BUY
$12.16 - $21.0 $66,211 - $114,345
5,445 Added 14.45%
43,117 $525,000
Q2 2019

Aug 13, 2019

BUY
$9.44 - $19.8 $91,001 - $190,872
9,640 Added 34.39%
37,672 $746,000
Q1 2019

May 06, 2019

SELL
$11.11 - $13.49 $10,087 - $12,248
-908 Reduced 3.14%
28,032 $343,000
Q4 2018

Feb 13, 2019

SELL
$10.24 - $15.49 $2,273 - $3,438
-222 Reduced 0.76%
28,940 $367,000
Q3 2018

Nov 09, 2018

BUY
$15.53 - $19.97 $27,099 - $34,847
1,745 Added 6.36%
29,162 $453,000
Q2 2018

Aug 08, 2018

BUY
$15.88 - $19.5 $357,824 - $439,393
22,533 Added 461.36%
27,417 $512,000
Q1 2018

May 07, 2018

BUY
$13.53 - $17.47 $1,501 - $1,939
111 Added 2.33%
4,884 $83,000
Q4 2017

Feb 09, 2018

BUY
$14.41 - $19.15 $3,602 - $4,787
250 Added 5.53%
4,773 $76,000
Q3 2017

Nov 09, 2017

BUY
$13.5 - $19.51 $61,060 - $88,243
4,523
4,523 $79,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.